Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its … A Greinacher, P Eichler, N Lubenow, H Kwasny, M Luz Blood, The Journal of the American Society of Hematology 96 (3), 846-851, 2000 | 459 | 2000 |
Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance A Zippelius, P Batard, V Rubio-Godoy, G Bioley, D Liénard, F Lejeune, ... Cancer research 64 (8), 2865-2873, 2004 | 449 | 2004 |
Rational design of new CpG oligonucleotides that combine B cell activation with high IFN‐α induction in plasmacytoid dendritic cells G Hartmann, J Battiany, H Poeck, M Wagner, M Kerkmann, N Lubenow, ... European journal of immunology 33 (6), 1633-1641, 2003 | 415 | 2003 |
Heparin‐induced thrombocytopenia: a prospective study on the incidence, platelet‐activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of … A Greinacher, D Juhl, U Strobel, A Wessel, N Lubenow, K Selleng, ... Journal of thrombosis and haemostasis 5 (8), 1666-1673, 2007 | 279 | 2007 |
Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia A Greinacher, N Lubenow, P Eichler Circulation 108 (17), 2062-2065, 2003 | 276 | 2003 |
Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin: incidence, effects on aPTT, and clinical relevance P Eichler, HJ Friesen, N Lubenow, B Jaeger, A Greinacher Blood, The Journal of the American Society of Hematology 96 (7), 2373-2378, 2000 | 274 | 2000 |
Lepirudin in patients with heparin-induced thrombocytopenia–results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3 N Lubenow, P Eichler, T Lietz, A Greinacher, Hit Investigators Group Journal of Thrombosis and Haemostasis 3 (11), 2428-2436, 2005 | 260 | 2005 |
Heparin-induced thrombocytopenia: temporal pattern of thrombocytopenia in relation to initial use or reexposure to heparin N Lubenow, R Kempf, A Eichner, P Eichler, LE Carlsson, A Greinacher Chest 122 (1), 37-42, 2002 | 251 | 2002 |
Incidence and clinical significance of anti‐PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin … D Juhl, P Eichler, N Lubenow, U Strobel, A Wessel, A Greinacher European journal of haematology 76 (5), 420-426, 2006 | 198 | 2006 |
The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopenia N Lubenow, P Hinz, S Thomaschewski, T Lietz, M Vogler, A Ladwig, ... Blood, The Journal of the American Society of Hematology 115 (9), 1797-1803, 2010 | 188 | 2010 |
Recombinant hirudin in clinical practice: focus on lepirudin A Greinacher, N Lubenow Circulation 103 (10), 1479-1484, 2001 | 181 | 2001 |
Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia: an analysis of 3 prospective studies N Lubenow, P Eichler, T Lietz, B Farner, A Greinacher Blood 104 (10), 3072-3077, 2004 | 178 | 2004 |
Profiling of alterations in platelet proteins during storage of platelet concentrates T Thiele, L Steil, S Gebhard, C Scharf, E Hammer, M Brigulla, N Lubenow, ... Transfusion 47 (7), 1221-1233, 2007 | 138 | 2007 |
CpG-A and CpG-B oligonucleotides differentially enhance human peptide–specific primary and memory CD8+ T-cell responses in vitro S Rothenfusser, V Hornung, M Ayyoub, S Britsch, A Towarowski, A Krug, ... Blood 103 (6), 2162-2169, 2004 | 138 | 2004 |
The new ID‐heparin/PF4 antibody test for rapid detection of heparin‐induced antibodies in comparison with functional and antigenic assays P Eichler, R Raschke, N Lubenow, O Meyer, P Schwind, A Greinacher British journal of haematology 116 (4), 887-891, 2002 | 122 | 2002 |
Heparin-induced thrombocytopenia in children: 12 new cases and review of the literature AF Klenner, N Lubenow, R Raschke, A Greinacher Thrombosis and haemostasis 91 (04), 719-724, 2004 | 113 | 2004 |
Heparin‐induced thrombocytopenia: towards standardization of platelet factor 4/heparin antigen tests A Greinacher, T Ittermann, J Bagemühl, K Althaus, B Fürll, S Selleng, ... Journal of thrombosis and haemostasis 8 (9), 2025-2031, 2010 | 96 | 2010 |
Standardizing the freeze‐thaw preparation of growth factors from platelet lysate G Strandberg, F Sellberg, P Sommar, M Ronaghi, N Lubenow, F Knutson, ... Transfusion 57 (4), 1058-1065, 2017 | 94 | 2017 |
Very low platelet counts in post-transfusion purpura falsely diagnosed as heparin-induced thrombocytopenia: report of four cases and review of literature N Lubenow, P Eichler, D Albrecht, LE Carlsson, J Kothmann, ... Thrombosis research 100 (3), 115-125, 2000 | 89 | 2000 |
Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift … N Lubenow, TE Warkentin, A Greinacher, A Wessel, DA Sloane, EL Krahn, ... Thrombosis research 117 (5), 507-515, 2006 | 88 | 2006 |